Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03334422 · COMPLETED
Trial details
- NCT number
- NCT03334422
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-12-12
- Enrollment
- 615
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.